← Back to Search

Behavioral Intervention

Mobile App + Brief Psychotherapy for Suicidal Thoughts

N/A

Recruiting

Led By EVAN KLEIMAN, Ph.D.

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult status (18+ years)

A recent suicide attempt or any report of current suicidal ideation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion (up to 28 days after inpatient hospital discharge)

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if learning three skills to manage negative emotions and receiving reminders on a smartphone to practice these skills can help reduce the frequency and intensity of emotional distress and suicidal thoughts."

Who is the study for?

This trial is for adults over 18 who have recently attempted suicide or are having suicidal thoughts. Participants must speak and write English fluently and own a smartphone with internet access. It's not for those unable to consent or participate fully due to cognitive impairments, intoxication, or violent behavior.

What is being tested?

The study tests if learning skills to manage negative emotions plus reminders on a mobile app can lessen emotional distress and suicidal thoughts. It compares usual treatment, ecological momentary assessment (EMA), and brief skills sessions with EMI prompts against standard care.

What are the potential side effects?

Since this trial involves psychotherapy supplemented by a mobile app rather than medication, typical medical side effects are not expected. However, participants may experience discomfort discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have not attempted suicide or had thoughts of suicide recently.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion (up to 28 days after inpatient hospital discharge)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion (up to 28 days after inpatient hospital discharge)

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion (up to 28 days after inpatient hospital discharge) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Between-condition differences in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment)

Within-person changes in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment) from pre- to post-EMI

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Treatment as usual (TAU) + EMAExperimental Treatment2 Interventions

Participants will receive TAU and be prompted to complete 4x/day smartphone-based EMA surveys of negative emotion and STBs.

Group II: Experimental intervention + TAUExperimental Treatment2 Interventions

Participants will receive TAU plus 3 brief sessions of CBT skills, one discretionary post-discharge skills booster session, and 4x/day EMA and prompted EMI, which guides in-the-moment CBT skills practice.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Treatment as usual (TAU)

2010

Completed Phase 3

~2710

0 / 2Eligibility criteria met